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Abstract
We describe a case of a splenic injury caused by a transsplenic percutaneous nephrostomy tract. The case was
completed without incident and the nephrostomy tube was noted to traverse the spleen on routine postoperative
imaging. This rare complication was managed by deposition of Gelfoam pledgets along the transsplenic
nephrostomy tract and placement of a ureteral stent. This novel management technique has not been previously
described in the literature and was successful in the conservative treatment of the uncommon complication of
splenic injury during percutaneous nephrolithotomy.
Introduction
Splenic injury is a rare but well-recognized complicationof percutaneous nephrolithotomy (PCNL). Treatment
options for this complication have been described in the lit-
erature, and range from observation to splenectomy. Evi-
dence regarding iatrogenic splenic injury supports splenic
preservation with either splenorrhaphy or other conservative
measures.1 We describe a case of splenic injury discovered
after PCNL, managed conservatively using a novel technique
of Gelfoam (Pfizer, New York, NY) insertion along the
transsplenic nephrostomy tract. In addition, we performed a
review of the literature to determine risk factors for inadver-
tent splenic injury as well as approaches to management of
this uncommon complication.
Case Report
A 62-year-old man presented with a 1-year history of left
flank and back pain. His medical history was remarkable for
hypertension and previous myocardial infarction. Computed
tomography (CT) revealed an abdominal aortic aneurysm
and a partial left-sided staghorn calculus with associated
moderate hydronephrosis. The majority of the stone occupied
the renal pelvis, measuring 2.72.1 cm. There were additional
stones in the lower pole, the largest measuring 2.01.0 cm
(Fig. 1). He underwent endoluminal repair of his abdominal
aortic aneurysm before seeking definitive management of the
staghorn calculus. After discussion of treatment options, the
patient elected to undergo PCNL.
Under fluoroscopic guidance, renal access was obtained
through an upper pole calix above the 11th rib. A guidewire
was passed and several attempts were made to negotiate it
down the ureter without success. After these attempts, an
Amplatz wire was coiled in the renal pelvis and the ne-
phrostomy tract was balloon dilated to 30F. The PCNL pro-
ceeded without complication. At the end of the procedure, a
7F nephroureteral stent was placed. There was no excessive
bleeding at the conclusion of the case. Nephrostomy tube
placement was confirmed fluoroscopically.
On postoperative day 1, a CT scan was obtained that
showed minimal residual stone. The nephrostomy tube was
noted to traverse the spleen on its course into the collect-
ing system (Fig. 2). There was no evidence of perisplenic
hemorrhage or free fluid in the abdomen. There was no
intraperitoneal-free air to suggest associated injury to the
stomach or bowel.
The patient did not demonstrate signs of bleeding or he-
modynamic instability. However, because of the course of the
nephrostomy tube through the spleen, a general surgery
consult was obtained; per their recommendations, the patient
was placed on bed rest and continuous cardiovascular
monitoring. Moderate gross hematuria was noted postop-
eratively, but the patient’s hematocrit level remained stable
and blood transfusion was not required.
On postoperative day 2, the patient was taken to the
interventional radiology suite for stent internalization and
removal of the nephroureteral stent. Specifically, the ne-
phroureteral stent was exchanged for a 9F vascular sheath,
and an 8F, 24 cm Double-J ureteral stent was placed over an
Amplatz guidewire with the proximal and distal ends coiling
in the renal pelvis and bladder, respectively. A sheet of Gel-
foam was cut into pieces and rolled into torpedo-shaped
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pledgets. Approximately five pledgets were deployed along
the transsplenic nephrostomy tract under fluoroscopic guid-
ance using the inner dilator to push them through the vascular
sheath as the sheath was slowly withdrawn.
The patient remained hemodynamically stable throughout
the remainder of hospitalization and did not require blood
transfusion. He was kept on bed rest until the hematuria re-
solved, and was discharged on postoperative day 5. The
ureteral stent was removed several weeks postoperatively
without incident. CT scan performed 1month postoperatively
showed minimal perinephric stranding and urothelial thick-
ening. The patient did not experience any long-term sequelae
or permanent disability as a result of the splenic injury.
Discussion
Risks associated with splenic injury
Iatrogenic splenic injuries are a known complication of left
renal surgery. Splenic injury can result in increased operative
time and blood loss, as well as a longer period of convales-
cence. In addition, splenic injury is associated with an in-
creased risk of infection, a near doubling of the rate of
morbidity, and increased risk of mortality.1 Recent trauma
literature supports splenic preservation because of the lifetime
risk of infectious complications that results from asplenism.2–4
Indeed, the syndrome of overwhelming postsplenectomy
sepsis is the most serious complication of splenectomy; mor-
tality is associated with splenectomy in 0.026% of adults and
0.052% of children.5 Prophylactic vaccinations while protec-
tive may not offer complete immunity because of both vac-
cination failure and the presence of other bacteria in at least
50% of overwhelming postsplenectomy sepsis cases.6
Splenic conservation has been increasingly utilized in both
adults and children without adverse outcome.7 If operative
management is warranted, however, most are salvageable by
splenorrhaphy or partial resection.2,4 In cases where addi-
tional placement of sutures is not optimal, the use of hemo-
static agents such as FloSeal (Baxter, Deerfield, IL) has been
described.8 In the current case and those of previously de-
scribed iatrogenic splenic injuries, hemostatic agents have
been effectively used.
Hemostatic agents
Hemostatic agents are designed to provide hemostasis by
accelerating the blood clotting process. Gelfoam, the hemo-
static agent used in this case, is a topical agent consisting of
porcine gelatin formed into a sponge that adheres to sites of
bleeding. Platelets are trapped in the uniform pores and the
clotting cascade is activated. In the case described herein,
Gelfoam pledgets were deployed along the previously de-
FIG. 1. Left partial staghorn calculus (A) and lower pole renal stone (B).
FIG. 2. Transsplenic percutaneous nephrostomy tube.
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veloped tract allowing adherence to bleeding sites along the
tract and activation of the clotting cascade. An internal ure-
teral stent was also left in place to allow healing of the col-
lecting system. The authors chose Gelfoam because of its ease
of deployment through a sheath and proven effectiveness in
hemostasis of liver biopsy tracts.9 The use of this hemostatic
agent has also been described for laceration of the right renal
artery during PCNL.10 FloSeal, composed of a gelatin matrix
in combination with a thrombin component, would have also
been a feasible alternative. The crosslinked gelatin granules in
the matrix expand approximately 20% when it comes into
contact with bodily fluids, thus slowing the flow of blood. The
thrombin component then activates the coagulation cascade.
In this case, it would expand to fill the splenic tract upon
contact followed by activation of the coagulation cascade and
formation of a hemostatic plug. The use of FloSeal has proven
effective in managing small-vessel bleeding associated with
partial nephrectomies.11,12
Other hemostatic agents that have been described in urologic
surgery include fibrin glue and BioGlue (CryoLife, Kennesaw,
GA). The use of fibrin glue, also known as fibrin sealant,
marketed as Tisseel (Baxter) and Hemaseel (Haemacure,
Sarasota, FL) has been described in a series of partial nephrec-
tomies after suture ligation of transected vessels.13 Fibrin glue
has also been successfully used for persistent urine leakage after
renal reconstruction after a gunshot wound and partial ne-
phrectomies.14–16 BioGlue, a liquid adhesive that rapidly poly-
merizes to form an impermeable seal, has been successfully
employed during partial nephrectomy to address minor splenic
injuries, including capsular tears and even mild laceration.17
Preventing splenic injury
Because of the anatomic relationship of the kidney with the
colon, duodenum, liver, spleen, and pleura, these structures
are at risk for injury during percutaneous renal access.18 In-
juries to the liver and spleen, however, are extremely rare.
Liver injuries, in all probability, are not likely a cause of major
morbidity as large drainage tubes are routinely placed during
biliary procedures. In addition, transhepatic PCNL has been
performed intentionally in cases of anatomic aberrancy.19
Splenic injuries, however, require at the very least conserva-
tive management, or possibly splenectomy in the event of
significant hemorrhage. Early diagnosis of this complication
is critical to prevent adverse outcomes. The possibility of
splenic injury should be an immediate consideration in the
event of hemodynamic instability after left-sided PCNL, even
in patients without significant hematuria.
For PCNL, a supracostal approach is preferred for the
treatment of upper pole stones, staghorn or complex calculi,
and stones in the proximal ureter20; however, the risk for
visceral injury is greater for tracts placed above the 12th rib.
To assess the safety of a supracostal approach, Hopper and
Yakes evaluated the potential course of a percutaneous access
tract on CT scans obtained during full inspiration and expi-
ration, finding that in the prone position, an 11th to 12th in-
tercostal approach would not be expected to puncture the
liver or spleen during expiration. However, in 14% and 29% of
cases, the tract would be expected to traverse the left and right
lung, respectively. A 10th to 11th intercostal approach during
expiration was associated with a risk of hepatic and splenic
injuries of 14% and 33%, respectively; in addition, the risk of
pleural injury increased to a rate of 86% for the left side and
93% for a right-sided puncture. These findings suggested that
punctures above the 11th rib carry a low risk of solid organ
injury, especially when placement is coupled with expira-
tion.21
For subcostal punctures, the likelihood of splenic injury is
low. The presence of splenomegaly, however, increases the
risk of injury. Ultrasound guidance during needle place-
ment significantly reduces the risk of splenic injury.22 In ad-
dition, preoperative cross-sectional imaging with CT or MRI
can further clarify structures adjacent to the kidney when a
supracostal puncture is planned.23
In general, the skin incision for puncture should lie between
the posterior axillary line and the spine to protect adjacent
organs from injury. The puncture site for percutaneous access
in thin patients should be more medial and superior.24 One
must also consider the chance for injury related to needle
placement along the horizontal axis of the body. A more lat-
eral placement of the catheter increases the possibility of in-
jury to the colon, liver, and spleen.25,26 Shah and colleagues27
recommend initial puncture medial to the posterior axillary
line during full inspiration to place the kidney in a subcostal
location, followed by needle insertion during exhalation to
shift the lung and spleen cephalad, thus avoiding the needle
path.
Superior pole access was utilized in this case based largely
on surgeon preference. Contemporary studies demonstrate
improved stone-free rates with a low incidence of pleural in-
juries with upper pole access.20,28 As such, we feel that the risk
of pleural injury should not impede selection of upper caly-
ceal access if deemed appropriate to maximize stone clear-
ance. Although a multiple-access approach is advocated by
some to avoid a supracostal puncture, its use has been found
to be associatedwith an increase in bleeding complications.28–31
Table 1. Management of Splenic Injury Detected After Left-Sided Percutaneous Nephrolithotomy
Author
No. of
patients Injury Management Transfusion
Schaeffer et al33 3 Splenic laceration (1) Observation None
Transsplenic catheter (2) Nephrostomy tube drainage (12–14 days) None
Shah et al27 2 Splenic laceration (1) Ex-lap, fibrin glue 3 units
Ruptured splenic hematoma (1) Splenectomy 4 units
Carey et al34 1 Transsplenic catheter Nephrostomy tube drainage (2 weeks) None
Santiago et al24 1 Splenic injury=hematoma Observation 1 unit
Goldberg et al10 1 Splenic puncture Observation Yes (quantity
not specified)
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Both upper pole andmultiaccess approaches have been found
to be viable with only a small increase in the incidence of
acceptable complications.28
A synchronous bidirectional approach that combines the
use of flexible instruments in a retrograde fashion as well as
through the nephrostomy tract to avoid multiple percutane-
ous punctures has also been described.32 We prefer to use a
single-access approach, utilizing the upper pole when neces-
sary, with the liberal use of flexible nephroscopy and retro-
grade intrarenal surgery to achieve optimal stone-free rates. In
general, each case should be individualized; the choice of
access, whether single or multiple, should be weighed against
potential risks without compromising stone clearance.
Conservative management
Although there are relatively few reports of splenic injury
during PCNL in the literature, several case reports have
identified spleen-preserving treatment options (Table 1).
Conservative management, including observation in a mon-
itored unit and serial measurements of hemoglobin or he-
matocrit levels, has been described.10,33
Santiago et al reported a case of small bowel and splenic
injury detected on CT obtained for abdominal pain, fever, and
postoperative anemia. The patient underwent exploratory
laparotomy for the small bowel injury, and the splenic he-
matoma was confirmed. The splenic injury was managed
expectantly.24 In cases where injury was discovered before
nephrostomy tube removal, some authors have left the
drainage catheter in place for 12 to 14 days.33,34 Schaeffer
et al33 reported nephrostomy tube removal followed by ob-
servation with serial hemodynamic and hemoglobin mea-
surements for 72 hours, whereas Carey and colleagues34
removed the nephrostomy tube after a negative antegrade
nephrostogram. Shah and associates reported two cases of
splenic injury, both requiring exploratory laparotomy; how-
ever, only one required splenectomy for ruptured hematoma.
In the second case, there was no active bleeding noted in-
traoperatively and fibrin glue was placed over the lacera-
tion.27 Lastly, splenectomy after PCNL for injuries not
amenable to conservative management has been reported
because of splenic perforation, ruptured hematoma, and ex-
cessive bleeding.27,35
In the series reported by Schaeffer et al,33 the greatest de-
gree of blood loss was in the patient whose injury was un-
recognized until the time of nephrostomy tube removal; the
other two injuries were incidentally detected before ne-
phrostomy tube removal, allowing prolonged catheter
drainage, and presumably decreased blood loss. The authors
speculated that a postoperative CT scan may be advisable
after upper pole puncture to avoid premature nephrostomy
tube removal in case of inadvertent injury. Others argue that
routine postoperative CT scanning is not cost effective con-
sidering the low incidence of visceral injury overall.27
Although extended nephrostomy tube drainage for trans-
splenic catheter placement has proven successful, it can be
disadvantageous for the patient. Prolonged placement of a
nephrostomy tube may be burdensome for the patient in
terms of increased postoperative pain as well as the incon-
venience of caring for an external drainage device. In the case
described herein, this injury was successfully managed
without the need for prolonged catheter drainage or blood
transfusion. This would undoubtedly improve patient quality
of life as well as decrease the risk of problems related to ex-
ternal drains and complications associated with the transfu-
sion of blood products.
Conclusions
Although relatively uncommon, iatrogenic splenic injury is
a recognized complication of PCNL. The lifelong risks asso-
ciated with asplenism suggest that splenic preservation and
nonoperative management should be strongly considered for
the hemodynamically stable patient. The use of hemostatic
agents for splenic injury is expanding, supporting prior re-
ports of success in managing a wide variety of splenic and
hepatic injuries. Although it is unclear whether a hemostatic
agentwas necessary in this case, its use appears prudentwhen
potential bleeding cannot be controlled by other means and
when hemostasis is not assured. Prospective studies com-
paring observation, various hemostatic agents, and ne-
phrostomy tube drainage are lacking, likely because of the
exceedingly low incidence of this complication.
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